Feasibility study of contralateral risk-reducing mastectomy with breast reconstruction for breast cancer patients with BRCA mutations in Japan

被引:0
|
作者
Akiyo Yoshimura
Seiko Okumura
Masataka Sawaki
Masaya Hattori
Junko Ishiguro
Yayoi Adachi
Haruru Kotani
Naomi Gondo
Ayumi Kataoka
Madoka Iwase
Sakura Onishi
Kayoko Sugino
Mitsuo Terada
Nanae Horisawa
Makiko Mori
Nobue Takaiso
Ikuo Hyodo
Hiroji Iwata
机构
[1] Aichi Cancer Hospital,Department of Breast Oncology
[2] Aichi Cancer Hospital,Department of Plastic and Reconstructive Surgery
[3] Aichi Cancer Center Research Institute,Division of Molecular Medicine
来源
Breast Cancer | 2018年 / 25卷
关键词
Hereditary breast and ovarian cancer; Risk reduction mastectomy; mutation; Breast reconstruction;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:539 / 546
页数:7
相关论文
共 50 条
  • [21] Contralateral risk-reducing local therapy in breast cancer patients with BRCA1/2 mutations: systemic review and meta-analysis
    Ziqi Jia
    Jiaxin Li
    Yuelun Zhang
    Xin Wang
    Jiahua Xing
    Zeyu Xing
    Xin Huang
    Gang Liu
    Menglu Zhang
    Kexin Feng
    Jiang Wu
    Wenyan Wang
    Jie Wang
    Jiaqi Liu
    Xiang Wang
    Cancer Cell International, 21
  • [22] Contralateral risk-reducing local therapy in breast cancer patients with BRCA1/2 mutations: systemic review and meta-analysis
    Jia, Ziqi
    Li, Jiaxin
    Zhang, Yuelun
    Wang, Xin
    Xing, Jiahua
    Xing, Zeyu
    Huang, Xin
    Liu, Gang
    Zhang, Menglu
    Feng, Kexin
    Wu, Jiang
    Wang, Wenyan
    Wang, Jie
    Liu, Jiaqi
    Wang, Xiang
    CANCER CELL INTERNATIONAL, 2021, 21 (01)
  • [23] The rate of incidental breast cancer in women with BRCA1/2 mutations who undergo bilateral risk-reducing mastectomy
    Thompson, Carlie
    Mooney, Bailey
    Moya, Jacky
    Lee, Minna
    DiNome, Maggie
    Baker, Jennifer
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (SUPPL 1) : 140 - 141
  • [24] Contralateral risk-reducing (prophylactic) mastectomy (RRM) in patients (pts) with breast cancer (BC): Experience at Mastologica Lomas Breast Center in Mexico City
    Sanchez-Forgach, E. R.
    Sanchez Basurto, C.
    Zabalaga, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (27)
  • [25] Risk-Reducing Mastectomy and Reconstruction Following Prophylactic Breast Irradiation: Hope Sustained
    Ben David, Merav A.
    Evron, Ella
    Rasco, Adi F.
    Shai, Ayelet
    Corn, Benjamin W.
    CANCERS, 2021, 13 (11)
  • [26] Risk-Reducing Mastectomy and Breast Reconstruction: Indications and Evidence for Current Management Strategies
    Eisemann, Bradley S.
    Spiegel, Aldona J.
    CLINICS IN PLASTIC SURGERY, 2018, 45 (01) : 129 - +
  • [27] Prophylactic contralateral mastectomy with immediate reconstruction in patients with unilateral breast cancer without germline BRCA1/2 mutations
    Lapena, Mara Cruellas
    Romea, Ismael Gil
    Esteban, Luis Mariano
    Ruiz, Carlos alvarez
    Marin, Natalia Alonso
    Diez, Maitane Ocariz
    Goni, Andrea Sesma
    Ruiz, Marta Gascon
    Garcia, Maria Zapata
    Berjaga, Maria Zurera
    Bielsa, Elisa Quilez
    Alejandro, Maria alvarez
    Ramon, Irene Torres
    Lozano, Pablo Andres Ordonez
    Inglan, Pilar Bueso
    Casado, Dolores Isla
    Conejero, Raquel Andres
    REVISTA DE SENOLOGIA Y PATOLOGIA MAMARIA, 2021, 34 (04): : 208 - 213
  • [28] Contralateral risk reducing mastectomy in patients with sporadic breast cancer. Benefits and hazards
    Boccardo, C.
    Gentilini, O.
    EJSO, 2016, 42 (07): : 913 - 918
  • [29] Implant-Based Breast Reconstruction after Risk-Reducing Mastectomy in BRCA Mutation Carriers: A Single-Center Retrospective Study
    Cammarata, Emanuele
    Toia, Francesca
    Rossi, Matteo
    Cipolla, Calogero
    Vieni, Salvatore
    Speciale, Antonino
    Cordova, Adriana
    HEALTHCARE, 2023, 11 (12)
  • [30] Efficacy of Bilateral Risk-reducing Mastectomy on Primary Breast Cancer Risk in Healthy BRCA1 and BRCA2 Mutation Carriers
    Heemskerk-Gerritsen, A.
    Hooning, M.
    Tilanus-Linthorst, M. M. A.
    Jager, A.
    van Deurzen, C. H. M.
    Collee, J. M.
    Menke-Pluymers, M. B. E.
    Seynaeve, C.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S75 - S75